Skip to content

The effect of Dermoline-henna on dermatitis due to radiation therapy

The effect of Dermoline- henna cream with Mometasone cream on radiodermatitis in breast cancer patients

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20200115046144N1
Enrollment
92
Registered
2020-03-04
Start date
2020-03-15
Completion date
Unknown
Last updated
2020-03-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Radiodermatitis. Radiodermatitis, unspecified

Interventions

Intervention 1: Intervention group: Cream Dermoline- hanna1/.%(oil of Lawsonia inermis, , Viola odorata, Cucurbita pepo) amount of one finger (FTU) will be applied uniformly with the index finger, at

Sponsors

Shahid Beheshti University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: Women with breast cancer undergoing radiotherapy Age range 18-70 years Grade 1 and 2 dermatitis Women whose breast is preserved

Exclusion criteria

Exclusion criteria: Untreated ulcer or scar and bacterial cellulite Diabetes, hypertension, collagen vascular disease, chronic skin diseases Simultaneous chemotherapy Grade 3 and higher dermatitis Chest deformity

Design outcomes

Primary

MeasureTime frame
Degree of dermatitis. Timepoint: 1 week after intervention,2week after intervention,3week after intervention,4week after intervention. Method of measurement: Criteria to determine the degree of dermatitis radiation Therapy Oncology Group (RTOG).

Secondary

MeasureTime frame
Itching. Timepoint: 1 week after intervention,2week after intervention,3week after intervention,4week after intervention. Method of measurement: Questioning the patient using a researcher-made questionnaire.;Pain. Timepoint: 1 week after intervention,2week after intervention,3week after intervention,4week after intervention. Method of measurement: Questioning the patient using a researcher-made questionnaire.;Burning. Timepoint: 1 week after intervention,2week after intervention,3week after intervention,4week after intervention. Method of measurement: Questioning the patient using a researcher-made questionnaire.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactBahareh Ahadi

Shahid Beheshti University of Medical Sciences

Drahadi89@GMAIL.COM+98 21 8877 3521

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 11, 2026